Nutrien Ltd. (NYSE:NTR) Shares Sold by Fmr LLC

FMR LLC cut its position in Nutrien Ltd. (NYSE:NTR - Free Report) by 5.5% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 10,059,373 shares of the company's stock after selling 587,890 shares during the quarter. FMR LLC owned 2.04% of Nutrien worth $483,415,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Bank of Montreal Can grew its position in Nutrien by 15.5% in the 2nd quarter. Bank of Montreal Can now owns 13,354,385 shares of the company's stock valued at $719,668,000 after acquiring an additional 1,794,333 shares in the last quarter. Silchester International Investors LLP boosted its stake in shares of Nutrien by 164.4% in the third quarter. Silchester International Investors LLP now owns 10,683,242 shares of the company's stock valued at $513,437,000 after purchasing an additional 6,642,075 shares during the period. 1832 Asset Management L.P. grew its holdings in shares of Nutrien by 1.9% in the second quarter. 1832 Asset Management L.P. now owns 9,006,528 shares of the company's stock valued at $458,522,000 after purchasing an additional 167,312 shares in the last quarter. Altshuler Shaham Ltd increased its stake in Nutrien by 8.1% during the 2nd quarter. Altshuler Shaham Ltd now owns 5,990,374 shares of the company's stock worth $304,970,000 after buying an additional 446,340 shares during the period. Finally, Dimensional Fund Advisors LP lifted its holdings in Nutrien by 8.4% during the 2nd quarter. Dimensional Fund Advisors LP now owns 5,145,375 shares of the company's stock worth $261,985,000 after buying an additional 399,348 shares in the last quarter. Hedge funds and other institutional investors own 63.10% of the company's stock.

Nutrien Stock Performance

NYSE NTR traded up $0.57 on Friday, reaching $46.66. The stock had a trading volume of 933,850 shares, compared to its average volume of 1,963,942. The company has a debt-to-equity ratio of 0.38, a quick ratio of 0.82 and a current ratio of 1.27. The stock has a market cap of $23.05 billion, a P/E ratio of 31.32, a price-to-earnings-growth ratio of 1.62 and a beta of 0.82. The business's 50-day moving average price is $47.93 and its 200 day moving average price is $49.76. Nutrien Ltd. has a 12-month low of $44.65 and a 12-month high of $60.87.

Nutrien (NYSE:NTR - Get Free Report) last released its quarterly earnings results on Wednesday, November 6th. The company reported $0.39 EPS for the quarter, missing the consensus estimate of $0.43 by ($0.04). Nutrien had a net margin of 2.79% and a return on equity of 6.99%. The business had revenue of $5.35 billion during the quarter, compared to analysts' expectations of $5.26 billion. During the same quarter last year, the company earned $0.35 EPS. The firm's revenue for the quarter was down 5.0% compared to the same quarter last year. As a group, equities analysts expect that Nutrien Ltd. will post 3.56 earnings per share for the current year.

Nutrien Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, January 17th. Investors of record on Tuesday, December 31st will be issued a dividend of $0.939 per share. The ex-dividend date is Tuesday, December 31st. This represents a $3.76 dividend on an annualized basis and a dividend yield of 8.05%. This is a positive change from Nutrien's previous quarterly dividend of $0.54. Nutrien's dividend payout ratio (DPR) is currently 144.97%.

Analyst Upgrades and Downgrades

Several equities analysts have commented on NTR shares. The Goldman Sachs Group downgraded shares of Nutrien from a "buy" rating to a "neutral" rating and dropped their price target for the stock from $69.00 to $53.00 in a research note on Tuesday, September 10th. BMO Capital Markets cut their price target on Nutrien from $80.00 to $75.00 and set an "outperform" rating on the stock in a report on Friday, August 9th. UBS Group cut Nutrien from a "buy" rating to a "neutral" rating and decreased their price objective for the company from $66.00 to $51.00 in a research note on Thursday, October 10th. Barclays cut their target price on shares of Nutrien from $68.00 to $55.00 and set an "overweight" rating on the stock in a research note on Friday, August 16th. Finally, Hsbc Global Res downgraded shares of Nutrien from a "hold" rating to a "moderate sell" rating in a research note on Friday, August 2nd. Three investment analysts have rated the stock with a sell rating, six have assigned a hold rating and ten have assigned a buy rating to the company's stock. Based on data from MarketBeat.com, Nutrien presently has a consensus rating of "Hold" and a consensus target price of $60.33.

Nutrien Profile

Nutrien Ltd. provides crop inputs and services. The company operates through four segments: Retail, Potash, Nitrogen, and Phosphate. The Retail segment distributes crop nutrients, crop protection products, seeds, and merchandise products. The Potash segment provides granular and standard potash products.